USPSTF Discourages Screening Asymptomatic Women for Ovarian Cancer
The United States Preventive Services Task Force has reaffirmed its 2004 recommendation statement against routine screening of asymptomatic women for ovarian cancer.
The United States Preventive Services Task Force has reaffirmed its 2004 recommendation statement against routine screening of asymptomatic women for ovarian cancer.
CBEC assessment might be justified for premenopausal women over age 40 years — even when abnormal bleeding is not established.
Frequent ovarian cancer screening does not increase anxiety or depression, but can increase the risk of a woman dropping out of the screening program soon after an abnormal test result.
Expression of the forkhead box M1 (FOXM1) transcription factor is associated with poor prognosis in early-stage cervical squamous cell carcinoma.
Histological subtypes appear to explain ethnic disparities in uterine cancer survival, according to a retrospective, single-institution study.
According to a study, type 2 diabetes mellitus is not associated with an increased risk of epithelial ovarian cancer.
LRP1B expression in women with high-grade serous cancer contributes to chemotherapy resistance.
HPV test, compared with Pap, at baseline better predicts CIN3 at follow-up of 18 years.
Patients with serous ovarian cancer BRCA2 mutations, but not BRCA1 mutations, have a survival advantage.
(ChemotherapyAdvisor) – Among women with ovarian cancer, the elderly and those with comorbidity are less likely to receive optimal surgical and medical treatment, a study reported in Gynecologic Oncology online July 15. However, while age 70 years and older was not found to be an independent poor prognostic factor, severe comorbidity was, noted Trine Lembrecht…